Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Magí Farré

Biographic Data

ID5481012
NAMEMagí Farré
GIVEN NAMESMagí
FAMILY NAMEFarré
SIGNATUREFARRÉ M
AFFILIATIONSInstitut Municipal d'Assistència Sanitària
VERIFIEDNo
TOTAL WORKS11
TOTAL CITATIONS0
AUTHOR COUNT11
EDITOR COUNT0
FIRST PUBLICATION YEAR2008
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Ayahuasca-assisted meaning reconstruction therapy for grief

    Open Access•Pablo Sabucedo, Óscar Andión et al.•ARTICLE•Frontiers in Psychiatry•2025

    https://clinicaltrials.gov, identifier NCT06150859

  • Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder

    Open Access•Nuria García‐Marchena, Nuria García-Marchena et al.•ARTICLE•International Journal of Mental…•2023

    Background The CohRTA multicenter study aims to characterize patients undergoing a first treatment for alcohol use disorder (AUD). The objective is to analyze sex-specific differences in the comorbidity of AUD when starting the first treatment for the disorder. Methods A multicenter study was carried out between 2014 and 2021 in 6 public centers in Spain. Sociodemographic characteristics were collected, variables related to alcohol consumption, m…

  • Synthetic cannabinoids use in a sample of opioid-use disorder patients

    Open Access•Maria Alías-Ferri, Manuela Pellegrini et al.•ARTICLE•Frontiers in Psychiatry•2022

    Cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. These substances are a type of new psychoactive substance that mimics the cannabis effects but often are more severe. Since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. In addition, these substances are not detecte…

  • BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression

    Open Access•Francina Fonseca, Joan Ignasi Mestre-Pintó et al.•ARTICLE•Frontiers in Psychiatry•2022

    Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment

  • Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries

    Open Access•Francina Fonseca, William Lenahan et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Non-medical use (NMU) of prescription GABA analogs (pregabalin and gabapentin) has been reported especially in opiate dependent persons. However, by now the prevalence of NMU of gabapentinoids in the general population has not been sufficiently evaluated. The aim of this research paper is to determine the prevalence of prescription GABA analog NMU and associated demographics in five European countries with special detail of Spain. Met…

  • A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder

    Open Access•Benjamin Keller, Joan Ignasi Mestre-Pintó et al.•ARTICLE•Frontiers in Psychiatry•2017

    The association of cocaine use disorder (CUD) and comorbid major depressive disorder (MDD; CUD/MDD) is characterized by high prevalence and poor treatment outcomes. CUD/MDD may be primary (primary MDD) or cocaine-induced (CUD-induced MDD). Specific biomarkers are needed to improve diagnoses and therapeutic approaches in this dual pathology. Platelet biomarkers [5-HT 2A receptor and imidazoline receptor antisera selected (IRAS)/nischarin] were ass…

  • The hidden web and the fentanyl problem

    Open Access•P Quintana, Mireia Ventura et al.•ARTICLE•International Journal of Drug…•2017

  • Something New about Something Old

    Álvaro José Palma-Conesa, Mireia Ventura et al.•ARTICLE•Journal of Psychoactive Drugs•2017

    New psychoactive tryptamines may be a public health risk since they intend to mimic the hallucinogenic effects of regulated psychoactive drugs. Few studies describe uses and clinical effects of unregulated new psychoactive tryptamines. This study aims (1) to explore the presence of tryptamines classified as NPS among the substances delivered for analysis to a harm-reduction organization; (2) to describe the substances found in the samples after a…

  • Potential Use of Ayahuasca in Grief Therapy

    Open Access•Débora González, Maria Carmo Carvalho et al.•ARTICLE•OMEGA - Journal of Death and Dying•2017

    The death of a loved one is ultimately a universal experience. However, conventional interventions employed for people suffering with uncomplicated grief have gathered little empirical support. The present study aimed to explore the potential effects of ayahuasca on grief. We compared 30 people who had taken ayahuasca with 30 people who had attended peer-support groups, measuring level of grief and experiential avoidance. We also examined themes …

  • Psychoactive drug or mystical incense? Overview of the online available information on Spice products

    Fabrizio Schifano, Ornella Corazza et al.•ARTICLE•International Journal of Culture…•2009•References: 2

    The aim of the study was to foster the collection and analysis of data from web pages related to information on the consumption, manufacture and sale of Spice products, a brand name for an herbal smoking blend, sold as legal substitute for cannabis. The Google search engine was used to carry out an 8-language qualitative assessment of information available on Spice products in a sample of about 200 web sites. The level of information elicited inc…

  • MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder

    José Carlos Bouso, Rick Doblin et al.•ARTICLE•Journal of Psychoactive Drugs•2008

    The purpose of this study was to investigate the safety of different doses of MDMA-assisted psychotherapy administered in a psychotherapeutic setting to women with chronic PTSD secondary to a sexual assault, and also to obtain preliminary data regarding efficacy. Although this study was originally planned to include 29 subjects, political pressures led to the closing of the study before it could be finished, at which time only six subjects had be…

No prominent works on this page.

  • MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder

    José Carlos Bouso, Rick Doblin et al.•ARTICLE•Journal of Psychoactive Drugs•2008

    The purpose of this study was to investigate the safety of different doses of MDMA-assisted psychotherapy administered in a psychotherapeutic setting to women with chronic PTSD secondary to a sexual assault, and also to obtain preliminary data regarding efficacy. Although this study was originally planned to include 29 subjects, political pressures led to the closing of the study before it could be finished, at which time only six subjects had be…

  • Psychoactive drug or mystical incense? Overview of the online available information on Spice products

    Fabrizio Schifano, Ornella Corazza et al.•ARTICLE•International Journal of Culture…•2009•References: 2

    The aim of the study was to foster the collection and analysis of data from web pages related to information on the consumption, manufacture and sale of Spice products, a brand name for an herbal smoking blend, sold as legal substitute for cannabis. The Google search engine was used to carry out an 8-language qualitative assessment of information available on Spice products in a sample of about 200 web sites. The level of information elicited inc…

  • A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder

    Open Access•Benjamin Keller, Joan Ignasi Mestre-Pintó et al.•ARTICLE•Frontiers in Psychiatry•2017

    The association of cocaine use disorder (CUD) and comorbid major depressive disorder (MDD; CUD/MDD) is characterized by high prevalence and poor treatment outcomes. CUD/MDD may be primary (primary MDD) or cocaine-induced (CUD-induced MDD). Specific biomarkers are needed to improve diagnoses and therapeutic approaches in this dual pathology. Platelet biomarkers [5-HT 2A receptor and imidazoline receptor antisera selected (IRAS)/nischarin] were ass…

  • The hidden web and the fentanyl problem

    Open Access•P Quintana, Mireia Ventura et al.•ARTICLE•International Journal of Drug…•2017

  • Something New about Something Old

    Álvaro José Palma-Conesa, Mireia Ventura et al.•ARTICLE•Journal of Psychoactive Drugs•2017

    New psychoactive tryptamines may be a public health risk since they intend to mimic the hallucinogenic effects of regulated psychoactive drugs. Few studies describe uses and clinical effects of unregulated new psychoactive tryptamines. This study aims (1) to explore the presence of tryptamines classified as NPS among the substances delivered for analysis to a harm-reduction organization; (2) to describe the substances found in the samples after a…

  • Potential Use of Ayahuasca in Grief Therapy

    Open Access•Débora González, Maria Carmo Carvalho et al.•ARTICLE•OMEGA - Journal of Death and Dying•2017

    The death of a loved one is ultimately a universal experience. However, conventional interventions employed for people suffering with uncomplicated grief have gathered little empirical support. The present study aimed to explore the potential effects of ayahuasca on grief. We compared 30 people who had taken ayahuasca with 30 people who had attended peer-support groups, measuring level of grief and experiential avoidance. We also examined themes …

  • Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries

    Open Access•Francina Fonseca, William Lenahan et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Non-medical use (NMU) of prescription GABA analogs (pregabalin and gabapentin) has been reported especially in opiate dependent persons. However, by now the prevalence of NMU of gabapentinoids in the general population has not been sufficiently evaluated. The aim of this research paper is to determine the prevalence of prescription GABA analog NMU and associated demographics in five European countries with special detail of Spain. Met…

  • Synthetic cannabinoids use in a sample of opioid-use disorder patients

    Open Access•Maria Alías-Ferri, Manuela Pellegrini et al.•ARTICLE•Frontiers in Psychiatry•2022

    Cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. These substances are a type of new psychoactive substance that mimics the cannabis effects but often are more severe. Since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. In addition, these substances are not detecte…

  • BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression

    Open Access•Francina Fonseca, Joan Ignasi Mestre-Pintó et al.•ARTICLE•Frontiers in Psychiatry•2022

    Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment

  • Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder

    Open Access•Nuria García‐Marchena, Nuria García-Marchena et al.•ARTICLE•International Journal of Mental…•2023

    Background The CohRTA multicenter study aims to characterize patients undergoing a first treatment for alcohol use disorder (AUD). The objective is to analyze sex-specific differences in the comorbidity of AUD when starting the first treatment for the disorder. Methods A multicenter study was carried out between 2014 and 2021 in 6 public centers in Spain. Sociodemographic characteristics were collected, variables related to alcohol consumption, m…

  • Ayahuasca-assisted meaning reconstruction therapy for grief

    Open Access•Pablo Sabucedo, Óscar Andión et al.•ARTICLE•Frontiers in Psychiatry•2025

    https://clinicaltrials.gov, identifier NCT06150859

Medicine (10 works) · Psychiatry (7 works) · Psychology (7 works) · Psychedelics and Drug Studies (5 works) · Forensic Toxicology and Drug Analysis (4 works) · Internal Medicine (4 works) · Pharmacology (4 works) · Cannabis and Cannabinoid Research (3 works) · Clinical Psychology (3 works) · Clinical Psychology (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae